Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.
From the official U.S. FDA label for zofenopril calcium, the active ingredient registered with NAFDAC.
take two tablets everty time, two times a day with enough water
- to prevent and cure the osteoporosis - to prevent and cure the disease of cardiac and vascular - to promote growth and healing
• Do not use during pregnant, breast-feeding, or menstrual cycle • Keep this product out of reach of children under 3 years old
Add the expiry date on your pack for a full Trust Score.
Bifril 30 mg Tablets contains Zofenopril calcium (30 mg), as tablet, according to its NAFDAC registration record.
Yes. Bifril 30 mg Tablets is listed on the NAFDAC register under registration number C4-1665, and its registration is active as of 28 October 2026.
No WHO falsified or substandard medical product alert currently matches Bifril 30 mg Tablets in our automatically synced alert list.
Run a free authenticity scan with the NAFDAC number C4-1665, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.
take two tablets everty time, two times a day with enough water (Summarised from the official U.S. FDA label for zofenopril calcium. Always follow your doctor or pharmacist.)
Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.